Sotagliflozin Clinical Trials
7 recruitingDrug
Phase 33Phase 22Phase 11Early Phase 11
Showing 1–7 of 7 trials
Recruiting
Phase 2
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
Heart FailureType 1 Diabetes
University of Dundee320 enrolled17 locationsNCT06435156
Recruiting
Phase 3
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Diabetic NephropathiesKidney Failure, Chronic
Alessandro Doria150 enrolled19 locationsNCT06217302
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
Non-obstructive Hypertrophic CardiomyopathyObstructive Cardiomyopathy, Hypertrophic
Lexicon Pharmaceuticals500 enrolled107 locationsNCT06481891
Recruiting
Early Phase 1
Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy Without Obstruction
University of Pennsylvania26 enrolled1 locationNCT06433050
Recruiting
Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression
Cardiac Sarcoidosis
University of Pennsylvania40 enrolled1 locationNCT06510894
Recruiting
Phase 3
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Heart FailureCardiovascular DiseasesType 1 Diabetes+1 more
Steno Diabetes Center Copenhagen2,000 enrolled2 locationsNCT06082063
Recruiting
Phase 1Phase 2
Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes
Type 1 Diabetes
University of California, San Diego24 enrolled1 locationNCT05696366